Study shows promising safety, patient outcomes data for MRI-guided adaptive radiation therapy to treat pancreatic cancer


Findings from a recent prospective study show promising safety and patient outcomes data for locally advanced and borderline resectable pancreatic cancer treatment using ablative Stereotactic MRI-Guided On-table Adaptive Radiation Therapy, also known as SMART. Approximately 25% of the study’s participants were patients treated at the Henry Ford Pancreatic Cancer Center (HFPCC).

England vs USA livestream: How to watch the FIFA 2022 World Cup match

Previous article

Epilepsy: Causes and risk factors

Next article

You may also like


Leave a reply

Your email address will not be published. Required fields are marked *

More in Innovations